RxDoctor Payments Data

Bryan Scott, DPM

Foot & Ankle Surgery · Chesapeake, VANPI 1558858456

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 80.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $5,239 and has fallen 96.9% since, to $164 in 2025.

$14,873in general payments, 2019–2025

Across 212 payments — averaging $70.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$12K
  • Southern Edge Orthopaedics, Inc.$2K
  • Smith+Nephew$180
  • Ossio Inc$155
  • Kerecis Limited$150
  • Paratek Pharmaceuticals, Inc.$122
  • plus $560 from 17 others

What the payments were for

  • Travel & lodging$5,75939%
  • Food & beverage$7,40550%
  • Education$1,70911%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,873 in reported general payments places this provider in the 80th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$70,952
Medicare patients
204
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole60$1,044
Ammonium Lactate27$454
Cephalexin29$194
Methylprednisolone16$106

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Chesapeake

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →